United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Replimune Group, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
| ROE | -107.88% | - | 103.4% | 53.17% | 37.2% | 29.59% |
|---|---|---|---|---|---|---|
| Sector average | 73.17% | 65.88% | 68.36% | 41.61% | 44.34% | 12.47% |
| ROA | -71.05% | -138.64% | -259.91% | -276.19% | -300.5% | -332.66% |
| Total Assets | $332,388.00K | $123,364.00K | $123,364.00K | $123,364.00K | $123,364.00K | $123,364.00K |
| Sector average | $3,537,396.33K | $3,954,880.66K | $4,602,556.36K | |||
| Net Income | -$313,940.00K | -$315,933.94K | -$320,630.64K | -$340,721.87K | -$370,710.78K | -$410,382.50K |
| $5,424,035.31K |
| $6,260,073.84K |
| $9,342,681.18K |